Latest updates on SARS-CoV-2 variants identified in the UK

The UK Health Security Agency (UKHSA) has published SARS-CoV-2 variant surveillance and assessment technical briefing 53. It contains the latest epidemiological and genomic analysis of the emergent BA.2.86 variant.

Online test nails early Alzheimer’s diagnosis with biomarker precision

Researchers have developed a novel digital cognitive testing platform, using the Oxford Cognitive Testing Portal, that correlates with serological biomarkers to accurately measure cognitive impairment

August 29, 2023

Lexeo Therapeutics pencils in $113M IPO for cardiac and Alzheimer’s gene therapy readouts in 2024

Executives at gene therapy startup Lexeo Therapeutics will likely make the 25-minute trek from their headquarters to Nasdaq’s trading floor later this week in the

October 31, 2023

Create Health Ventures Launches $21M VC Fund for Digital Health

What You Should Know: – Create Health Ventures, a venture capital firm dedicated to early-stage digital health startups, announced the closing of its $21M inaugural

August 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.